{"id":58061,"date":"2026-04-30T06:48:24","date_gmt":"2026-04-30T06:48:24","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/58061\/"},"modified":"2026-04-30T06:48:24","modified_gmt":"2026-04-30T06:48:24","slug":"bgi-and-roche-launch-affordable-alzheimers-diagnostic-tests-in-china-ethealthworld","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/58061\/","title":{"rendered":"BGI and Roche Launch Affordable Alzheimer’s Diagnostic Tests in China, ETHealthworld"},"content":{"rendered":"

\"\"\/ Shanghai: BGI Genomics<\/a> and Roche Diagnostics<\/a> have \u200drolled out tests for Alzheimer’s disease<\/a> in China, the companies said, in \u2060an effort to expand access to easier-to-use diagnosis and monitoring choices for patients with the brain-wasting condition.<\/p>\n

In a statement, BGI Genomics<\/a> said doctors are \u200cusing a \u200cblood test it developed as an auxiliary tool in Guangzhou, Qingdao, Shenzhen and Wuhan to \u200cevaluate the disease’s progression and the risk of onset.<\/p>\n

Switzerland’s Roche also said in a statement that its team in China was working with a local regulatory authority to make its own test measuring \u200bpTau181, a key protein associated with Alzheimer’s \u200bdisease, available to patients in Boao, Hainan province.<\/p>\n

The Roche test \u200cwas put \u200dinto clinical use at a hospital in Boao, \u200dthe official Hainan Daily reported on Monday. Roche \u200cdid not respond to questions related to the report.<\/p>\n

Blood tests could speed up diagnosis of the disease and make it easier to access treatments such as Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla, since traditional tests are often costly or uncomfortable.<\/p>\n

Other options to detect Alzheimer’s include \u200da spinal tap, which requires an invasive puncture to collect spinal fluid, or an expensive PET brain scan.<\/p>\n

BGI \u200dGenomics said \u2060its test cannot \u2060be used as standalone evidence for an Alzheimer’s diagnosis and treatment, citing a possibility of a small number of failures, but doctors said it was helpful for early screening.<\/p>\n

Roche said a negative test for pTau181 with its product meant “most people can avoid further unnecessary investigations for Alzheimer’s using CSF (cerebrospinal fluid) or PET and can be put on the appropriate pathway for their condition.” <\/p>\n

(Editing by Miyoung Kim and Thomas Derpinghaus)\n <\/p>\n

Published On Jan 14, 2026 at 05:27 PM IST<\/p>\n

\n Join the community of 2M+ industry professionals.
\n Subscribe to Newsletter to get latest insights & analysis in your inbox.\n <\/p>\n

All about ETHealthworld industry right on your smartphone! <\/p>\n

\"\"\/ <\/p>\n","protected":false},"excerpt":{"rendered":"Shanghai: BGI Genomics and Roche Diagnostics have \u200drolled out tests for Alzheimer’s disease in China, the companies said,…\n","protected":false},"author":2,"featured_media":58062,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[15909,13065,32286,32287,134,2057],"class_list":["post-58061","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-alzheimers-disease","tag-bgi-genomics","tag-blood-test-for-alzheimers","tag-diagnostic-tests-in-china","tag-roche","tag-roche-diagnostics"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116492324516957246","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/58061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=58061"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/58061\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/58062"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=58061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=58061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=58061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}